NEWPORT BEACH, Calif.--(BUSINESS WIRE)--April 06, 2000--DermaRx
Corporation (OTCBB:DMRX) and GoPublicNow.com, Inc. a Nevada
corporation announced today that GoPublicNow.com has completed its
merger with and into DermaRx and has changed the name of the surviving
corporation to GoPublicNow.com, Inc.
    The combined entities are scheduled to trade on the
over-the-counter bulletin board on April 7, 2000 under the symbol
"GNOW" which is being changed from "DMRX".
    The officers and directors of GoPublicNow.com preceding the merger
remain the officers and directors of the surviving corporation,
including its President and Chairman, Bruce Berman.
    DermaRx also announced today that it had completed a reverse stock
split of its shares reflecting one share for every five shares issued
and outstanding prior to the reverse stock split.
    As a result of the merger, GoPublicNow.com has the following
information available to the public:
-0-
*T
 
Public Float:                      approximately 750,000
Shares Outstanding (common):       approximately 11,500,000
Shares Outstanding (preferred):    approximately 0
 
Shares Authorized (common):        100,000,000
Shares Authorized (preferred):     10,000,000
*T
 
    In order to view the site, please click on the following link:
www.GoPublicNow.com
    GoPublicNow.com intends to be recognized as a premier full service
business-to-business Internet-based investment management firm and Web
portal site. GPN specializes in the ability to provide any business or
entrepreneur that wants to seek capital and/or go public in the US
markets, a single source solution to assist them with their financing
and business development needs. Acting as a virtual incubator, GPN
intends to be a single source answer for those needs. Not only will
GPN provide access to funding sources and the public markets, the
Company will guide clients through the proper channels in order for
them to smoothly make the transition into a public entity.
    Included in this release are "forward-looking statements" within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
Although the company believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations reflected in such forward-looking statements
will prove to have been correct. The company's actual results could
differ materially from those anticipated in the forward-looking
statements as a result of certain factors including sales levels,
distribution and competition trends and other market factors.